Results 361 to 370 of about 5,184,059 (400)
Some of the next articles are maybe not open access.
Current Opinion in Oncology, 2006
This article will review the diagnosis and management of bladder cancer at each stage, from superficial to metastatic disease with an emphasis on recent developments over the last year.Bacille Calmette-Guerin is the most effective therapy for carcinoma in situ.
Eric S, Gwynn, Peter E, Clark
openaire +2 more sources
This article will review the diagnosis and management of bladder cancer at each stage, from superficial to metastatic disease with an emphasis on recent developments over the last year.Bacille Calmette-Guerin is the most effective therapy for carcinoma in situ.
Eric S, Gwynn, Peter E, Clark
openaire +2 more sources
The Lancet, 2016
Bladder cancer is a complex disease associated with high morbidity and mortality rates if not treated optimally. Awareness of haematuria as the major presenting symptom is paramount, and early diagnosis with individualised treatment and follow-up is the key to a successful outcome.
Ashish M, Kamat +8 more
openaire +2 more sources
Bladder cancer is a complex disease associated with high morbidity and mortality rates if not treated optimally. Awareness of haematuria as the major presenting symptom is paramount, and early diagnosis with individualised treatment and follow-up is the key to a successful outcome.
Ashish M, Kamat +8 more
openaire +2 more sources
Current Opinion in Oncology, 2000
There is a need for the development of reliable tumor markers in bladder cancer. A number of studies this past year focused on the evaluation of urinary markers that hold promise as noninvasive adjuncts to traditional diagnostic or surveillance techniques, principally urinary cytology and cystoscopy.
H, Ozen, M C, Hall
openaire +2 more sources
There is a need for the development of reliable tumor markers in bladder cancer. A number of studies this past year focused on the evaluation of urinary markers that hold promise as noninvasive adjuncts to traditional diagnostic or surveillance techniques, principally urinary cytology and cystoscopy.
H, Ozen, M C, Hall
openaire +2 more sources
International Urogynecology Journal and Pelvic Floor Dysfunction, 1999
Bladder cancer is seen mainly in men. The incidence in women is increasing, but is still approximately three to four times lower than in men. In particular transitional cell cancers seem relatively more common in men then in women (ratio 4:1), but non-transitional cell cancer is also more frequent in men (ratio 2.7: 1).
Poel, H.G. van der +2 more
openaire +4 more sources
Bladder cancer is seen mainly in men. The incidence in women is increasing, but is still approximately three to four times lower than in men. In particular transitional cell cancers seem relatively more common in men then in women (ratio 4:1), but non-transitional cell cancer is also more frequent in men (ratio 2.7: 1).
Poel, H.G. van der +2 more
openaire +4 more sources
Current Opinion in Oncology, 2007
This article reviews the diagnosis and management of bladder cancer with an emphasis on studies and developments over the past year.Cystoscopy remains the mainstay in the detection and surveillance of bladder cancer, though efforts continue in the development of urinary bladder cancer markers.
openaire +2 more sources
This article reviews the diagnosis and management of bladder cancer with an emphasis on studies and developments over the past year.Cystoscopy remains the mainstay in the detection and surveillance of bladder cancer, though efforts continue in the development of urinary bladder cancer markers.
openaire +2 more sources
Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.
Journal of Clinical Oncology, 2001PURPOSE To evaluate our long-term experience with patients treated uniformly with radical cystectomy and pelvic lymph node dissection for invasive bladder cancer and to describe the association of the primary bladder tumor stage and regional lymph node ...
J. Stein +11 more
semanticscholar +1 more source
Epidemiology of Bladder Cancer
European Urology, 1999Item does not contain ...
Aben, K.K.H., Kiemeney, L.A.L.M.
openaire +4 more sources
European Urology, 2008
Patients with bladder cancer face a variable risk of recurrence based on their clinical characteristics and the biology of their disease. Physicians need tools to accurately estimate the risk of recurrence and cancer-specific mortality to recommend individualized therapy and to design appropriate clinical trials.A MEDLINE literature search was ...
Shariat Shahrokh F. +4 more
openaire +3 more sources
Patients with bladder cancer face a variable risk of recurrence based on their clinical characteristics and the biology of their disease. Physicians need tools to accurately estimate the risk of recurrence and cancer-specific mortality to recommend individualized therapy and to design appropriate clinical trials.A MEDLINE literature search was ...
Shariat Shahrokh F. +4 more
openaire +3 more sources
Radiology, 2019
Background The Vesical Imaging-Reporting and Data System (VI-RADS) scoring system was created in 2018 to standardize imaging and reporting of bladder cancer staging with multiparametric MRI.
Huanjun J Wang +9 more
semanticscholar +1 more source
Background The Vesical Imaging-Reporting and Data System (VI-RADS) scoring system was created in 2018 to standardize imaging and reporting of bladder cancer staging with multiparametric MRI.
Huanjun J Wang +9 more
semanticscholar +1 more source